Hamamatsu Photonics Announces U.S. FDA clearance for the NanoZoomer S360MD Slide scanner system for Surgical Pathology Diagnostics
Another manufacturer has FDA clearance for primary diagnosis for clinical use. Be sure to check out the NanoZoomer S260MD slide scanner for primary diagnostics.
Hamamatsu Photonics K.K., a global leader in imaging technology, today announces that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to market the NanoZoomer S360MD Slide scanner system for primary diagnostic use. The NanoZoomer S360MD Slide scanner system is a high-throughput automated digital slide creation, viewing, and management system that can aid pathologists in the viewing and diagnosis of surgical pathology slides.
This FDA clearance comes at an ideal time when healthcare organizations are actively evolving the integration of advanced digital techniques, global connectivity, and human capabilities to optimize patient outcomes and maximize operational efficiencies. Digital pathology systems are aimed at this critical intersection of health, informatics, engineering and equalization, by elevating pathologists’ expertise and streamlining laboratory workflow while also increasing diagnostic confidence. At Hamamatsu, every product that we build is created with a mind for precision and longevity. We are excited that our FDA clearance now brings our flagship digital slide scanner technology into the world of clinical use.
Source: Hamamatsu Photonics
